MX2017007741A - Formulaciones de calcio y fosfato para inflamacion oral. - Google Patents

Formulaciones de calcio y fosfato para inflamacion oral.

Info

Publication number
MX2017007741A
MX2017007741A MX2017007741A MX2017007741A MX2017007741A MX 2017007741 A MX2017007741 A MX 2017007741A MX 2017007741 A MX2017007741 A MX 2017007741A MX 2017007741 A MX2017007741 A MX 2017007741A MX 2017007741 A MX2017007741 A MX 2017007741A
Authority
MX
Mexico
Prior art keywords
phosphate
calcium
liquid
formulations
oral inflammation
Prior art date
Application number
MX2017007741A
Other languages
English (en)
Other versions
MX372952B (es
Inventor
Gosselin Patrick
Betancourt Aimesther
Weldon Bartholomew
Kobus Edward
Dumoulin Sandryne
Original Assignee
Valeant Pharmaceuticals Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeant Pharmaceuticals Int Inc filed Critical Valeant Pharmaceuticals Int Inc
Publication of MX2017007741A publication Critical patent/MX2017007741A/es
Publication of MX372952B publication Critical patent/MX372952B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere en general, a composiciones líquidas y métodos para tratar inflamación oral administrando una composición líquida a la cavidad oral. La composición líquida se prepara a partir de un polvo que contiene glicerofosfato de calcio, una o más sales de fosfato de sodio, cloruro de sodio, y opcionalmente bicarbonato de sodio y sílice. El polvo se mezcla con una cantidad de agua para formar un líquido que es supersaturado con iones de calcio y de iones de fosfato y está esencialmente libre de partículas y precipitados visibles.
MX2017007741A 2014-12-17 2015-12-15 Formulaciones de calcio y fosfato para inflamacion oral. MX372952B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462093026P 2014-12-17 2014-12-17
PCT/CA2015/051327 WO2016095036A1 (en) 2014-12-17 2015-12-15 Formulations of calcium and phosphate for oral inflammation

Publications (2)

Publication Number Publication Date
MX2017007741A true MX2017007741A (es) 2018-05-02
MX372952B MX372952B (es) 2020-04-03

Family

ID=56125518

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007741A MX372952B (es) 2014-12-17 2015-12-15 Formulaciones de calcio y fosfato para inflamacion oral.

Country Status (10)

Country Link
US (2) US11590165B2 (es)
EP (1) EP3233092B1 (es)
JP (1) JP6781701B2 (es)
KR (1) KR102397070B1 (es)
CN (1) CN107530374B (es)
AU (1) AU2015367208B2 (es)
BR (1) BR112017013158B1 (es)
CA (1) CA2971224C (es)
MX (1) MX372952B (es)
WO (1) WO2016095036A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765650B2 (en) * 2016-02-03 2020-09-08 Forward Science Technologies, LLC Artificial saliva
US10143635B2 (en) 2016-02-03 2018-12-04 Forward Science Technologies, LLC Artificial saliva
GR1009399B (el) * 2017-06-23 2018-11-15 Χρηστος Γεωργιου Φυτας Στοματικο διαλυμα κατα της ξηροστομιας και στοματοφαρυγγικης βλεννογονιτιδας
WO2023183556A2 (en) * 2022-03-24 2023-09-28 Amcyte Pharma, Inc. Treatment for retinal disorders

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB572352A (en) * 1944-02-26 1945-10-03 Charles Somerville Dillon Improved tooth powder or preparation
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5540913A (en) 1987-03-17 1996-07-30 Turner; Robert E. Formulations and uses thereof in the prevention and treatment of oral lesions
US5268267A (en) 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
US5427768A (en) 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
JPH11500724A (ja) * 1995-02-24 1999-01-19 アメリカン デンタル アソシエイション ヘルス ファウンデーション 石灰化組織の処置、鉱化及びフッ化物化用の炭酸塩化した溶液及びその使用方法
CA2224274C (en) 1995-08-08 2001-07-31 Enamelon, Inc. Remineralizing products and methods for teeth
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
ES2197364T3 (es) 1996-09-18 2004-01-01 Erling Johansen Baño bucal comprendiendo iones de calcio y fosfato en solucion sobresaturada.
US6159448A (en) * 1996-09-27 2000-12-12 Enamelon, Inc. Products and methods for the remineralization and prevention of demineralization of teeth
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
JP4669960B2 (ja) 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US20070185194A1 (en) * 2003-07-01 2007-08-09 Kamal Mehta Stable oral compositions of azithromycin monohydrate
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
US8518383B2 (en) * 2006-02-03 2013-08-27 Wm. Wrigley Jr. Company Oral care products comprising buffer systems for improved mineralization/remineralization benefits
CA2648460C (en) * 2006-04-05 2014-09-23 Cadbury Adams Usa Llc Calcium phosphate complex and salts in oral delivery systems
TWI445540B (zh) * 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
JP5166780B2 (ja) * 2007-06-20 2013-03-21 花王株式会社 液体口腔用組成物
WO2009012393A1 (en) * 2007-07-18 2009-01-22 The Curators Of The University Of Missouri Pharmaceutical composition comprising a proton pump inhibitor and protein component
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US20090130232A1 (en) 2007-11-20 2009-05-21 Mohammed Zahra Composition and method for treatment of oral inflammation an ulceration
TW200934385A (en) * 2007-12-21 2009-08-16 Alcon Res Ltd Stabilized glycerophosphate-containing surgical irrigating solution
JP2011512416A (ja) * 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
JP2009235012A (ja) 2008-03-28 2009-10-15 Gc Corp 口腔湿潤用組成物
WO2010054494A2 (en) 2008-11-14 2010-05-20 Profimed S.R.O. Biomimetic oral care composition
CN101584889B (zh) 2009-07-10 2012-12-12 山东大学威海分校 一种用于治疗牙周病的外用原位成型基质
US20110086108A1 (en) 2009-10-12 2011-04-14 Bartholomew Weldon Dissolving powders that can be mixed with water and used as an oral rinse
JP5485677B2 (ja) 2009-12-16 2014-05-07 花王株式会社 口腔用組成物
KR101953076B1 (ko) * 2010-08-07 2019-05-22 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 구강 건조를 완화시키거나 또는 감소시키는 방법
EP2919744B1 (en) * 2012-11-16 2020-09-02 EUSA Pharma (UK) Ltd Effervescent tablet

Also Published As

Publication number Publication date
CN107530374A (zh) 2018-01-02
MX372952B (es) 2020-04-03
AU2015367208A1 (en) 2017-08-03
JP2018505862A (ja) 2018-03-01
AU2015367208B2 (en) 2021-04-01
BR112017013158A2 (pt) 2018-04-10
US20230241102A1 (en) 2023-08-03
KR102397070B1 (ko) 2022-05-16
CA2971224C (en) 2020-09-22
CN107530374B (zh) 2021-07-27
EP3233092A4 (en) 2018-08-01
US20160175356A1 (en) 2016-06-23
BR112017013158B1 (pt) 2023-05-02
EP3233092B1 (en) 2019-09-04
US11590165B2 (en) 2023-02-28
CA2971224A1 (en) 2016-06-23
WO2016095036A1 (en) 2016-06-23
EP3233092A1 (en) 2017-10-25
KR20170105517A (ko) 2017-09-19
JP6781701B2 (ja) 2020-11-04

Similar Documents

Publication Publication Date Title
MX2018003775A (es) Composiciones para el cuidado bucal y metodos de uso.
MX2022005380A (es) Composiciones que comprenden colina.
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
AR093792A1 (es) Composiciones que contienen zinc estables al fluoruro
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
BR112015031726A2 (pt) composição para tratamento bucal à prova de manchas
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
BR112018011210A2 (pt) métodos para inibir a conversão de carnitina em trimetilamina (tma)
BR112016015851A2 (pt) Formulações farmacêuticas estabilizadas de insulina aspart
BR112017004572A2 (pt) composição de limpeza encapsulada, e, método para formar uma composição de limpeza encapsulada.
MY176246A (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
BR112016004358A8 (pt) combinação farmacêutica de um inibidor de alk e um inibidor de cdk para tratamento de doenças proliferativas de célula, composição farmacêutica, seus usos, e kit
MX374628B (es) Formulacion que comprende un agente hipolipidemico.
BR112018016032A2 (pt) composto, composição farmacêutica e método para melhorar um distúrbio
EA201890193A1 (ru) Композиция для ухода за полостью рта
MX340619B (es) Metodo para reducir la transpiracion y composiciones antitranspirantes.
BR112018010950A2 (pt) composição de creme dental, método de promoção da remineralização dos dentes e usos de argila e silicato
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
AR101188A1 (es) Composiciones orales anticálculo
BR112019006087A2 (pt) composição de cuidados bucais e método para beneficiar dentes de um indivíduo
MX372952B (es) Formulaciones de calcio y fosfato para inflamacion oral.
BR112015015872A2 (pt) composição de tratamento oral
CL2016003155A1 (es) Composiciones de cuidado bucal
BR112017021611A2 (pt) ?composição para os cuidados orais, método para o branqueamento e/ou remineralização dos dentes e conjunto para os cuidados orais?
BR112015014092A2 (pt) administração oral transmucosal de acetato de glatirâmer

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: FP MARANGONI INC.